Bristol-Myers Squibb bags immunotherapy unicorn – Chemistry World (subscription)
|
Bristol-Myers Squibb bags immunotherapy unicorn
Chemistry World (subscription) US drugmaker Bristol-Myers Squibb (BMS) has agreed to buy Boston-based startup IFM Therapeutics. The deal gives BMS rights to IFM’s two preclinical cancer programmes – stimulator of interferon genes (Sting) and NLRP3 agonist drugs that work with the … |
|
Lung Stem Cells Close to Treating IPF, Other Lung Fibrosis Diseases, Say NC Researchers
Pulmonary Fibrosis News Researchers at two universities in North Carolina have developed a new method to expand stem cells isolated from patient’s lung biopsies. A team led by Dr. Jason Lobo, assistant professor of medicine at the University of North Carolina (UNC), and by Ke … |
New Scientist |
First implants derived from stem cells to ‘cure’ type 1 diabetes | New …
New Scientist Two people have been given implants of cells derived from embryonic stem cells that may be able to release insulin when needed to manage blood sugar … Scientists Move One Step Closer To “Curing” Diabetes Using First …Futurism Scientists may have found a functional cure for type-1 diabetesEngadget |
Evening Standard |
Surgeons focus on stem cell transplants to help save sight of acid attack victims
Evening Standard Eye doctors are fast-tracking efforts to improve stem cell transplants to save the sight of people blinded in London’s acid attack epidemic, the Standard can reveal. Research at The Royal Free Hospital aims to boost success rates, particularly where … |